Literature DB >> 26697772

Patient-centred care in established rheumatoid arthritis.

M J H Voshaar1, I Nota2, M A F J van de Laar3, B J F van den Bemt4.   

Abstract

Review of the evidence on patient-centred care (PCC) in rheumatoid arthritis (RA) shows that involving the patient as an individual - with unique needs, concerns and preferences - has a relevant impact on treatment outcomes (safety, effectiveness and costs). This approach empowers patients to take personal responsibility for their treatment. Because clinicians are only able to interact personally with their patients just a few hours per year, patients with a chronic condition such as RA should be actively involved in the management of their disease. To stimulate this active role, five different PCC activities can be distinguished: (1) patient education, (2) patient involvement/shared decision-making, (3) patient empowerment/self-management, (4) involvement of family and friends and (5) physical and emotional support. This article reviews the existing knowledge on these five PCC activities in the context of established RA management, especially focused on opportunities to increase medication adherence in established RA.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Medication adherence; Patient education; Patient empowerment; Patient-centred care; Rheumatoid arthritis; Self-management; Shared decision-making

Mesh:

Year:  2015        PMID: 26697772     DOI: 10.1016/j.berh.2015.09.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  29 in total

Review 1.  Managing rheumatic and musculoskeletal diseases - past, present and future.

Authors:  Gerd R Burmester; Johannes W J Bijlsma; Maurizio Cutolo; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

2.  Disease activity-based management of rheumatoid arthritis in Dutch daily clinical practice has improved over the past decade.

Authors:  Marieke J Spijk-de Jonge; Julia M Weijers; Marlies E J L Hulscher; Piet L C M van Riel; Laura W M Boerboom; Anita M P Huis; Femke Atsma; Laura T C Van Hulst; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2020-01-29       Impact factor: 2.980

3.  A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a Center of Excellence in Colombia.

Authors:  Pedro Santos-Moreno; Nelson J Alvis-Zakzuk; Laura Villarreal-Peralta; Maria Carrasquilla-Sotomayor; Angel Paternina-Caicedo; Nelson Alvis-Guzmán
Journal:  Rheumatol Int       Date:  2017-12-16       Impact factor: 2.631

Review 4.  Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect.

Authors:  Mourad F Rezk; Burkhard Pieper
Journal:  Rheumatol Ther       Date:  2017-10-14

5.  Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment.

Authors:  Michael Schiff; Shane Saunderson; Irina Mountian; Paul Hartley
Journal:  Rheumatol Ther       Date:  2017-09-27

6.  Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists.

Authors:  Monika Hifinger; Mickael Hiligsmann; Sofia Ramiro; Verity Watson; Florian Berghea; Márta Péntek; Andrew Keat; Johan L Severens; Bruno Fautrel; Annelies Boonen
Journal:  RMD Open       Date:  2017-09-04

7.  Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products.

Authors:  Carlos M González; Loreto Carmona; Javier de Toro; Enrique Batlle-Gualda; Antonio I Torralba; María J Arteaga; Luis Cea-Calvo
Journal:  Patient Prefer Adherence       Date:  2017-07-19       Impact factor: 2.711

8.  Patients' conceptions of their own influence on good treatment response to biological therapy in chronic inflammatory arthritis.

Authors:  Ingrid Larsson
Journal:  Patient Prefer Adherence       Date:  2017-06-26       Impact factor: 2.711

9.  Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods.

Authors:  Ingrid Nota; Constance H C Drossaert; Heleen C Melissant; Erik Taal; Harald E Vonkeman; Cees J Haagsma; Mart A F J van de Laar
Journal:  BMC Med Inform Decis Mak       Date:  2017-04-26       Impact factor: 2.796

10.  Apps for People With Rheumatoid Arthritis to Monitor Their Disease Activity: A Review of Apps for Best Practice and Quality.

Authors:  Rebecca Grainger; Hermaleigh Townsley; Bonnie White; Tobias Langlotz; William J Taylor
Journal:  JMIR Mhealth Uhealth       Date:  2017-02-21       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.